Related references
Note: Only part of the references are listed.The GPI-Linked Protein LY6A Drives AAV-PHP.B Transport across the Blood-Brain Barrier
Juliette Hordeaux et al.
MOLECULAR THERAPY (2019)
Positron emission tomography reporter gene strategy for use in the central nervous system
Tom Haywood et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Surface chemistry of gold nanoparticles determines interactions with bovine serum albumin
Gongke Wang et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2019)
Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsids
Qin Huang et al.
PLOS ONE (2019)
Viral Strategies for Targeting the Central and Peripheral Nervous Systems
Claire N. Bedbrook et al.
ANNUAL REVIEW OF NEUROSCIENCE, VOL 41 (2018)
Gene therapy clinical trials worldwide to 2017: An update
Samantha L. Ginn et al.
JOURNAL OF GENE MEDICINE (2018)
The Neurotropic Properties of AAV-PHP.B Are Limited to C57BL/6J Mice
Juliette Hordeaux et al.
MOLECULAR THERAPY (2018)
RNA-guided transcriptional silencing in vivo with S. aureus CRISPR-Cas9 repressors
Pratiksha I. Thakore et al.
NATURE COMMUNICATIONS (2018)
Oligonucleotide conjugated multi-functional adeno-associated viruses
Dhruva Katrekar et al.
SCIENTIFIC REPORTS (2018)
Structural and functional insights into S-thiolation of human serum albumins
Fumie Nakashima et al.
SCIENTIFIC REPORTS (2018)
Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction
Zachary Fitzpatrick et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Trafficking of adeno-associated virus vectors across a model of the blood-brain barrier; a comparative study of transcytosis and transduction using primary human brain endothelial cells
Steven F. Markel et al.
JOURNAL OF NEUROCHEMISTRY (2017)
Site-Specific PEGylated Adeno-Associated Viruses with Increased Serum Stability and Reduced Immunogenicity
Tianzhuo Yao et al.
MOLECULES (2017)
First AAV gene therapy poised for landmark approval
Eric Smalley
NATURE BIOTECHNOLOGY (2017)
Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems
Ken Y. Chan et al.
NATURE NEUROSCIENCE (2017)
Radioiodinated Capsids Facilitate In Vivo Non-Invasive Tracking of Adeno-Associated Gene Transfer Vectors
P. Kothari et al.
SCIENTIFIC REPORTS (2017)
Overcoming the Host Immune Response to Adeno-Associated Virus Gene Delivery Vectors: The Race Between Clearance, Tolerance, Neutralization, and Escape
Federico Mingozzi et al.
ANNUAL REVIEW OF VIROLOGY, VOL 4 (2017)
Site Specific Modification of Adeno-Associated Virus Enables Both Fluorescent Imaging of Viral Particles and Characterization of the Capsid Interactome
Jayanth S. Chandran et al.
SCIENTIFIC REPORTS (2017)
Targeting the Brain with Nanomedicine
Felix Rueda et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Inverse electron demand Diels-Alder reactions in chemical biology
B. L. Oliveira et al.
CHEMICAL SOCIETY REVIEWS (2017)
Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
Michael F. Naso et al.
BIODRUGS (2017)
A Precise Chemical Strategy To Alter the Receptor Specificity of the Adeno-Associated Virus
Rachel E. Kelemen et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
An essential receptor for adeno-associated virus infection
S. Pillay et al.
NATURE (2016)
Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain
Benjamin E. Deverman et al.
NATURE BIOTECHNOLOGY (2016)
Quantitative imaging of protein targets in the human brain with PET
Roger N. Gunn et al.
PHYSICS IN MEDICINE AND BIOLOGY (2015)
Targeted Delivery of Protein and Gene Medicines Through the Blood-Brain Barrier
W. M. Pardridge
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Recombinant Adeno-Associated Virus: Efficient Transduction of the Rat VMH and Clearance from Blood
Margriet A. van Gestel et al.
PLOS ONE (2014)
Quantitative, noninvasive, in vivo longitudinal monitoring of gene expression in the brain by co-AAV transduction with a PET reporter gene
Sea Young Yoon et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2014)
Immune responses to AAV vectors: overcoming barriers to successful gene therapy
Federico Mingozzi et al.
BLOOD (2013)
Endocytic processing of adeno-associated virus type 8 vectors for transduction of target cells
Y. Liu et al.
GENE THERAPY (2013)
Site-Specific Modification of Adeno-Associated Viruses via a Genetically Engineered Aldehyde Tag
Yarong Liu et al.
SMALL (2013)
Structural Insight into the Unique Properties of Adeno-Associated Virus Serotype 9
Michael A. DiMattia et al.
JOURNAL OF VIROLOGY (2012)
Glycated AAV Vectors: Chemical Redirection of Viral Tissue Tropism
Eric D. Horowitz et al.
BIOCONJUGATE CHEMISTRY (2011)
Immune Responses to AAV in Clinical Trials
Federico Mingozzi et al.
CURRENT GENE THERAPY (2011)
Terminal N-Linked Galactose Is the Primary Receptor for Adeno-associated Virus 9
Shen Shen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The AAV9 receptor and its modification to improve in vivo lung gene transfer in mice
Christie L. Bell et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
A Potential Role of Distinctively Delayed Blood Clearance of Recombinant Adeno-associated Virus Serotype 9 in Robust Cardiac Transduction
Nicole M. Kotchey et al.
MOLECULAR THERAPY (2011)
Engineering Liver-detargeted AAV9 Vectors for Cardiac and Musculoskeletal Gene Transfer
Nagesh Pulicherla et al.
MOLECULAR THERAPY (2011)
BALB/c Mice Show Impaired Hepatic Tolerogenic Response Following AAV Gene Transfer to the Liver
Ekaterina Breous et al.
MOLECULAR THERAPY (2010)
Site-specific modification of AAV vector particles with biophysical probes and targeting ligands using biotin ligase
Matthew D. Stachler et al.
MOLECULAR THERAPY (2008)
PEG conjugation moderately protects adeno-associated viral vectors against antibody neutralization
GK Lee et al.
BIOTECHNOLOGY AND BIOENGINEERING (2005)
Thiol-reactive dyes for fluorescence labeling of proteomic samples
K Tyagarajan et al.
ELECTROPHORESIS (2003)
Adenovirus-facilitated nuclear translocation of adeno-associated virus type 2
W Xiao et al.
JOURNAL OF VIROLOGY (2002)
Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by Rac1 and phosphatidylinositol-3 kinase activation
S Sanlioglu et al.
JOURNAL OF VIROLOGY (2000)
Graphical analysis of PET data applied to reversible and irreversible tracers
J Logan
NUCLEAR MEDICINE AND BIOLOGY (2000)
Evaluation of fecal mutagenicity and colorectal cancer risk
TMCM de Kok et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2000)
Share Paper
